SEUM advised Linewalks with respect to its recent funding round through which it raised KRW 1.9 Billion from Kakao Investment. Regarding the investment, Linewalk’s CEO Yong-hyun Cho remarked “[through this funding round] we will expand our customers and partners, and we will develop technology and increase our human resources to enhance our experience in customer data as well.”

Linewalks is a data analytic service focusing primarily on the medical and financial sectors. For example, its MDwalks service, which collects and analyzes data to predict industry needs and demands, is used by many domestic and international healthcare companies such as Johnson & Johnson Medical and GlaxoSmithKline. Later in 2018 Linewalks plans to launch a Clinical Decision Support System (CDSS), designed to assist physicians and other health professionals with decision-making tasks, through an A.I. technology driven program and in collaboration with various medical institutions such as Asan Medical Center.

The SEUM team was comprised of partner Hoseok Jung.